AIM IMMUNOTECH INC. Proceeds from Sale of Held-to-maturity Securities
AIM IMMUNOTECH INC. (AIM) reported Proceeds from Sale of Held-to-maturity Securities of $96.00 thousand for the 3-month period ending 2025-03-31, per its 10-Q filed 2025-05-15.
Financial Statements › Cash Flow › Investing Activities
us-gaap:ProceedsFromSaleOfHeldToMaturitySecurities · last filed 2025-05-15
- AIM IMMUNOTECH INC. proceeds from sale of held-to-maturity securities for the quarter ending 2025-03-31 was $96.00K, a 31.51% increase year-over-year.
- AIM IMMUNOTECH INC. proceeds from sale of held-to-maturity securities for the quarter ending 2024-03-31 was $73.00K.
| Period end | Proceeds from Sale of Held-to-maturity Securities 3 month |
|---|---|
| 2025-03-31 | $96.00K 10-Q · filed 2025-05-15 |
| 2024-03-31 | $73.00K 10-Q · filed 2025-05-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| Silexion Therapeutics Corp (SLXN) | $0.001B |